Lucane Pharma’s strategy for growth follows three main pathways: Successful development of own drugs, co-development of drugs and In/out Licensing of drugs.

Lucane Pharma is actively engaged in the development of 9 products, each of which will offer a significant benefit to patients suffering from very rare disorders who have to take medication every day of their lives to survive or to reduce the pathological complications of their disease.